Cargando…

Comment on: Martelletti et al. Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation

In this letter, we present the Austrian proposal for diagnostic criteria of refractory chronic migraine and we discuss the consensensus statement of the European Headache Feaderation. We focus in particular on the definition of adequate prophylactic treatment, the management of medication overuse an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wöber, Christian, Wessely, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266543/ https://www.ncbi.nlm.nih.gov/pubmed/25418797 http://dx.doi.org/10.1186/1129-2377-15-77

Ejemplares similares

Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2014)

Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
por: Martelletti, Paolo, et al.
Publicado: (2014)

European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
por: Sacco, Simona, et al.
Publicado: (2020)

Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation
por: Mitsikostas, Dimos D, et al.
Publicado: (2014)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation
por: Lampl, Christian, et al.
Publicado: (2014)

Trigger factors of migraine and tension-type headache: experience and knowledge of the patients
por: Wöber, C., et al.
Publicado: (2006)

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
por: Sacco, Simona, et al.
Publicado: (2021)

Neuromodulation of chronic headaches: position statement from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2013)

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2017)

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
por: Sacco, Simona, et al.
Publicado: (2018)

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2018)

European headache federation consensus on technical investigation for primary headache disorders
por: Mitsikostas, D. D., et al.
Publicado: (2016)

Consensus Statement on the definition and classification of metabolic hyperferritinaemia
por: Valenti, Luca, et al.
Publicado: (2023)

The Polish Headache Society and the Headache Section of the Polish Neurological Society Consensus Statement: update on new pharmacological therapies for migraine in clinical practice and public medication reimbursement program for chronic migraine
por: Domitrz, Izabela, et al.
Publicado: (2022)

Refractory migraine in a headache clinic population
por: Irimia, Pablo, et al.
Publicado: (2011)

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine
por: Kouremenos, Evangelos, et al.
Publicado: (2019)

Comments on Reinhart et al.: consensus statement of the ESICM task force on colloid volume therapy in critically ill patients
por: Zacharowski, Kai, et al.
Publicado: (2012)

Première of a partnership: European Headache Federation and The Journal of Headache and Pain
por: Martelletti, P., et al.
Publicado: (2006)

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)
por: Fanciulli, Alessandra, et al.
Publicado: (2018)

Improvement of refractory migraine headache by propofol: case series
por: Soleimanpour, Hassan, et al.
Publicado: (2012)

Portuguese Football Federation consensus statement 2020: nutrition and performance in football
por: Abreu, Rodrigo, et al.
Publicado: (2021)

Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
por: Seddon, James A., et al.
Publicado: (2013)

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
por: Raffaelli, Bianca, et al.
Publicado: (2023)

European Headache Federation recommendations for placebo and nocebo terminology
por: Mitsikostas, Dimos D., et al.
Publicado: (2020)

European Headache Federation guideline on idiopathic intracranial hypertension
por: Hoffmann, Jan, et al.
Publicado: (2018)

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
por: Vatzaki, Efstratia, et al.
Publicado: (2018)

Comment to the article: “Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension” by Jordan and colleagues
por: Moreno Velásquez, Ilais, et al.
Publicado: (2022)

Comments on the review article ‘Antidromic vasodilatation and the migraine mechanism’ by Geppetti et al. in the Journal of Headache and Pain 2012; 13:103–111
por: Shevel, Elliot
Publicado: (2012)

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
por: Lampl, Christian, et al.
Publicado: (2023)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023)

Comorbidity of headache in children and adolescence
por: Wöber-Bingöl, Çiçek
Publicado: (2013)

Sarcopenia: revised European consensus on definition and diagnosis
por: Cruz-Jentoft, Alfonso J, et al.
Publicado: (2019)

Sarcopenia: revised European consensus on definition and diagnosis
por: Cruz-Jentoft, Alfonso J, et al.
Publicado: (2019)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Guidelines for telematic second opinion consultation on headaches in Europe: on behalf of the European Headache Federation (EHF)
por: Pereira-Monteiro, José, et al.
Publicado: (2010)

Saudi Arabian Consensus Statement on Vagus Nerve Stimulation for Refractory Epilepsy
por: Alqadi, Khalid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_divec3cg6f0f7l4opnp0sm45iv